Medicare puts off decision on lowering drug prices patients pay at the pharmacy
Medicare has made no decision on whether discounts that pharmacy benefit managers negotiate for drugs should be passed on to patients.
WASHINGTON — The Centers for Medicare and Medicaid Services laid out a bevy of initiatives Monday that officials said would reduce drug prices for patients covered by the Medicare Part D prescription drug
